Setmelanotide
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
Rhythm · Phase 3 · Active, not recruiting · Enrollment 143
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Setemelanotide | n/r | n/r | n/r | n/r |
| Placebo | n/r | 0.05% | n/r | n/r |
| Setmelanotide | n/r | 55.6% | n/r | n/r |
Not shown
- Setemelanotide: endpoint not reported